Effects of aprotinin application on perioperative changes in hemostasis and fibrinolysis and its consequence for blood loss and transfusion requirement in lung surgery;EFFEKTE DER INTRAOPERATIVEN APROTINAPPLIKATION AUF PERIOPERATIVE HAEMOSTASE- UND FIBRINOLYSEVERANDERUNGEN UND IHRE AUSWIRKUNGEN AUF BLUTVERLUST UND TRANSFUSIONSBEDARF BEI LUNGENCHIRURGISCHEN EINGRIFFEN

Infusionstherapie und Transfusionsmedizin

Volumn 25, Issue 4, 1998, Pages 236-245

  Katzel R ^a   Keuper, H ^b   Wiedemann, B ^c   Brethner, L ^d   Voigt, B ^a  

^a Klinikum St Georg   (Germany)

^b Behring Diagnostics GmbH   (Germany)

^c Klin F Anasthesiologie I   (Germany)

^d Klinikums St Georg gGmbH   (Germany)

Author keywords

Aprotinin; Inhibition of fibrinolysis; Reduction of blood loss; Thoracic surgery

Indexed keywords

ANTITHROMBIN III; APROTININ; BLOOD CLOTTING FACTOR 8; FIBRIN; PLACEBO; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE CONCENTRATE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MALE; RANDOMIZED CONTROLLED TRIAL; THORAX SURGERY;

EID: 0031902718     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Baehle PL, Riuz-Gomez J, Londot C, Sauvage M, Van Dyck MJ, Robert A: Systematic use of aprotinin in cardiac surgery: Influence on total homologous exposure and hospital cost. Acta Anaesthesiol Belg 1992;43:103-112.
2. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T: Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993;55:971-976.
3. Cosgrove DM III, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LAR, Stewart RW, McCarthy PM, Loop FD: Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study. Ann Thorac Surg 1992;54:1031-1038.
4. Dietrich W: Kann durch Medikamente der operative Blutverlust reduziert werden? in Martin E, Fleischer F (Hrsg): Perioperative Gerinnungsstörungen. Diagnostik und Therapie. Berlin, Springer, 1993, pp 111-122.
5. Lemmer JH, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, Holt WW, Karp RB, Laub GW, Lipton MJ, Schaff HV, Tatooles CJ, Rumberger JA: Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994;107:543-553.
6. Orchard MA, Goodschild CS, Prentice CRM, Davies JA, Benoit SE, Creighthon-Kemsford LJ, Gaffney PJ, Michelson AD: Aprotinin reduces cardio-pulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets. Thromb Haemost 1993;69:936(Abstract 1426).
7. Santoli E, DiMattia DG, Castelli P, Condemi A, Guzzetti St, Meraviglia P, Santoli C: Reduction of homologous transfusions in open-heart surgery. Vasc Surg 1992;26:693-699.
8. Thompson JF, Roath OS, Francis JL, Webster JHH, Chant ADB: Aprotinin in vascular surgery. Lancet 1990;335:911.
9. Janssens M, Joris J, David JL, Lemaire R, Lamy M: High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 1994;80:23-29.
10. Murkin JM, Shannon NA, Bourne RB, Rorabeck CH, Cruickshank M, Wyile G: Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty. Anesth Analg 1995;80: 343-348.
11. Ullrich W, Henn-Beilharz A, Schmitt Y, Holz U, Krier C: Der Einsatz von Aprotinin beim trabekulär orientierten Hüftgelenksersatz: Blutverlust und Gerinnungsveränderungen; in Mempel W, Schwarzfischer G, Mempel C (Hrsg): Eigenbluttransfusion heute. Hämatologie. München, Sympomed, 1995, vol. 4, pp 212-218.
12. Wollinsky KH, Mehrkens HH, Freytag T, Geiger P, Weindler M: Vermindert Aprotinin den intraoperativen Blutverlust? Anästhesiol Intensivmed Notfallmed Schmerzther 1991;26:208-210.
13. Grosse H, Lobbes W, Frambach M, von Broen O, Ringe B, Barthels M: The use of high dose aprotinin in liver transplantation: The influence on fibrinolysis and blood loss. Thromb Res 1991;63:287-297.
14. Himmelreich G, Bechstein WO, Riess H: Aprotinin in liver transplantation. Biomed Prog 1993;6:40-43.
15. Domenech P, Marinez-Brotons F, Garcia L, Sabater A, Espanol I: Influence of aprotinin on intraoperative blood loss and changes in coagulation and fibrinolysis in orthotopic liver transplantation (olt). Throm Haemost 1995;73:1428(Abstract 2017).
16. Francis JL, Francis DA, Palmer JD: Aprotinin reduces blood loss during surgery for meningioma. Thromb Haemost 1995;73:984(Abstract 327).
17. Le Querrec A, Derlon A, Tartiere J, Bricard H, Hurpe JM, Samba D, Tazerout M, Salaun V, Thomas M: Effect of aprotinin infusion during surgical procedure associated with haemorrhaghic shock. Thromb Haemost 1993;69:794(Abstract 897).
18. Valentine S, Williamson P, Sutton D: Reduction of acute haemorrhage with aprotinin. Anaesthesia 1993;48:405-406.
19. Blauhut B, Gross C, Necek S, Doran JE, Späth P, Lundsgard-Hansen P: Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;101: 958-967.
20. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH: Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:788-797.
21. Primack C, Walenga JM, Koza MJ, Shankey TV, Sullivan HJ, Montoya A, Pifarre R: Aprotinin modulation of platelet activation in cardiopulmonary bypass patients. Thromb Haemost 1995;73:1346 (Abstract 1710).
22. Huang H, Ding W, Su Z, Zhang W: Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993;106:11-18.
23. Bennett JL, Doyle L, Shaw J, Doran BRH, Keenan DJM, Douglas JT: Aprotinin in cardiac surgery: How a varying dosage modifies circulating levels of d-dimer and soluble fibrin. Thromb Haemost 1995;73:1140(Abstract 919).
24. Marx G, Pokar H, Reuter H, Doering V, Tilsner V: The effects of aprotinin on hemostatic function during cardiac surgery. J Cardiothor Vasc Anesth 1991;5:467-474.
25. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister HE: Aprotinin in cardiopulmonary bypass-effects on the hageman factor (FXII)-kallikrein system and blood loss. Blood Coagul Fibrinolysis 1992;3: 99-104.
26. Kim T, Hoppensteadt D, Moran S, Koza M, Walenga JM, Sullivan H, Montoya A, Farced J, Pifarre R: The effect of aprotinin treatment during cabg on TFPI, tissue factor and other hemostatic parameters. Thromb Haemost 1993;69:1290(Abstract 2673).
27. Kätzel R, Wiedemann B, Keuper H, Brethner B: The effect of the anaesthesia procedure on intraoperative fibrinolysis activation and postoperative fibrinolytic shut-down. Fibrinolysis 1994;8:309-316.
28. Kätzel R, Lösche W, Selle B: Zur Messung der spontanen Thrombozytenaggregation im Zitratvollblut (SPAV) unter Verwendung des hämostaseologischen Automaten Coulter S plus VI. Z Med Labordiagn 1991;32:44-49.
29. Kätzel R, Lutze G, Selle B: Kinetische Fibrinogen-bestimmung mit Batroxobin (Reptilase). Z Ges Inn Med 1991;46:708-711.
30. Siegert G: Einsatz von Fibrinplatten in der Fibrinolysediagnostik. Z Med Labordiagn 1988;29:400-404.
31. Harker LA, Malpass TW, Branson HE, Hessel EA Jr, Slichter SJ: Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with relective alphagranula release. Blood 1980;56: 824-834.
32. Kätzel R, Till U, Wiedemann B, Brethner L: Changes in platelet behaviour during thoracic surgery. Platelets 1990;1:52(Abstract).
33. Kätzel R, Wiedemann B, Selle B, Straube A: Untersuchungen zum mittleren Thrombozytenvolumen (MPV) in der perioperativen Phase mit dem Coulter Counter S plus VI. Z Klin Med 1989; 44:1249-1252.
34. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Caprini JA: Decreased platelet number and function and increased fibrinolysis contribution to postoperative bleeding in cardiopulmonary bypass patients. Throm Haemost 1988;59:62-67.
35. Francis JL, Howard C: The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin. Blood Coagul Fibrinolysis 1993;4:35-40.
36. Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB: In vitro effects of aprotinin on activated clotting time measured with different activators. J Thorac Cardiovasc Surg 1992;104:1135-1140.
37. Kätzel R, Wiedemann B, Heidel HJ: Antithrombin-III-Bestimmung in der perioperativen Phase unter den Bedingungen der limitierten isovolämischen Hämodilution. Z Klin Med 1987;42:1647-1650.
38. Wendel HP, Heller W, Gallimore MJ: The effect of aprotinin on chromogenic peptide substrate and other assays for compensation, fibrinolysis and plasma kallikrein systems. Fibrinolysis 1994;8:304-308.
39. Johnson EJ, Hariman H, Hampton KK, Grant PJ, Davies JA, Prentice CRM: Fibrinolysis during major abdominal surgery. Fibrinolysis 1990;4:147-151.
40. Kluft C, Verheijen JH, Jie AFH, Sue-Ling HH, Jespersen J, Aasan O: The postoperative fibrinolytic shut-down: A rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest 1985;45:605-610.